Troponin Elevations Only Detected With a High‐sensitivity Assay: Clinical Correlations and Prognostic Significance

Abstract

On the initial sample, 9% to 11% of subjects without cTnI elevation had hsTnI elevation. Although the majority of the patients with these newly detected hsTnI elevations did not have ACS, they had a higher risk for all-cause mortality and subsequent cardiac hospitalization.